Biotricity, Inc. (NASDAQ:BTCY)

WEB NEWS

Friday, July 16, 2021

Research

Key takeaway from BTCY Interview

Biotricity is a medical technology company that provides biometric data monitoring solutions. 

The CEO sees triple digit growth for the next 2 years. Our challenge is deciding if shares are worth paying up for, given that they are trading at an EV/S of ~41. Also note that BTCY will have to raise a substantial amount of money to continue to develop new products. 

The company’s most current investor presentation can be found here.

We have also scheduled a live virtual presentation and Q&A with BTCY for Monday June 19th at 4:15 PM EST.



Market Data powered by QuoteMedia. Terms of Use